Superficial mycosis
ICD-10 B36 is a billable code used to indicate a diagnosis of superficial mycosis.
Superficial mycosis refers to a group of fungal infections that primarily affect the outer layers of the skin, hair, and nails. These infections are typically caused by dermatophytes, yeasts, or non-dermatophyte molds. Common examples include tinea (ringworm), candidiasis, and pityriasis versicolor. The clinical presentation may vary from mild scaling and itching to more severe inflammatory responses, depending on the pathogen and host factors. Diagnosis is often made through clinical examination and may be confirmed with laboratory tests such as KOH preparations or fungal cultures. Treatment usually involves topical antifungal agents, such as clotrimazole or terbinafine, although systemic therapy may be necessary for extensive or resistant cases. Patients who are immunocompromised, such as those with HIV/AIDS, diabetes, or undergoing chemotherapy, are at increased risk for more severe manifestations of superficial mycosis and may require more aggressive treatment and monitoring. Understanding the nuances of these infections is crucial for effective management and coding.
Detailed clinical notes including lesion description, location, and treatment response.
Diagnosis and treatment of tinea corporis, tinea pedis, and onychomycosis.
Ensure accurate identification of the fungal type and any underlying conditions.
Comprehensive patient history, including immunocompromised status and previous infections.
Management of recurrent fungal infections in immunocompromised patients.
Document any systemic treatments and their outcomes.
Used to confirm the diagnosis of superficial mycosis.
Document the reason for the culture and the site from which the sample was taken.
Dermatology may require more detailed documentation regarding the clinical findings.
Superficial mycosis affects the outer layers of skin, hair, and nails, while deep mycosis involves deeper tissues and organs, often requiring more aggressive treatment.
